loadpatents
name:-0.020082235336304
name:-0.048065900802612
name:-0.013324022293091
The J. David Gladstone Institutes, A Testamentary Trust Established Under the Will of J. David Gladstone Patent Filings

The J. David Gladstone Institutes, A Testamentary Trust Established Under the Will of J. David Gladstone

Patent Applications and Registrations

Patent applications and USPTO patent grants for The J. David Gladstone Institutes, A Testamentary Trust Established Under the Will of J. David Gladstone.The latest application filed is for "methods for inducing cell division of postmitotic cells".

Company Profile
10.31.1
  • The J. David Gladstone Institutes, A Testamentary Trust Established Under the Will of J. David Gladstone - San Francisco CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Modified non-natural NKG2D ligands that selectively deliver attached heterologous molecules to non-natural NKG2D receptors on car-cells
Grant 11,440,948 - Kim , et al. September 13, 2
2022-09-13
Methods and compositions for treating obesity and/or diabetes and for identifying candidate treatment agents
Grant 11,376,242 - Huang , et al. July 5, 2
2022-07-05
Automated robotic microscopy systems
Grant 11,361,527 - Finkbeiner , et al. June 14, 2
2022-06-14
Methods and compositions for producing pancreatic beta cells
Grant 11,332,716 - Hebrok , et al. May 17, 2
2022-05-17
Methods of treating disease by metabolic control of T-cell differentiation
Grant 11,241,455 - Xu , et al. February 8, 2
2022-02-08
In vitro assays for inhibition of microglial activation
Grant 11,099,172 - Akassoglou , et al. August 24, 2
2021-08-24
Compositions and methods for reactivating latent immunodeficiency virus
Grant 11,098,309 - Ott , et al. August 24, 2
2021-08-24
Method of determining cellular protein homeostasis
Grant 11,020,463 - Conklin , et al. June 1, 2
2021-06-01
Methods for treatment of retinal disease by photoreceptor gene expression modulation
Grant 10,849,904 - Reh , et al. December 1, 2
2020-12-01
Reversible stencils for fabricating micro-tissues
Grant 10,851,344 - Huebsch , et al. December 1, 2
2020-12-01
Methods for inducing cell division of postmitotic cells
Grant 10,669,596 - Mohamed , et al.
2020-06-02
Methods For Inducing Cell Division Of Postmitotic Cells
App 20200165691 - Mohamed; Tamer M.A. ;   et al.
2020-05-28
Substituted benzoxazine and related compounds
Grant 10,611,741 - Tsvetkov , et al.
2020-04-07
Small molecule cellular reprogramming to generate neuronal cells
Grant 10,500,232 - Lin , et al. Dec
2019-12-10
Methods for treatment of retinal disease by photoreceptor gene expression modulation
Grant 10,363,256 - Reh , et al.
2019-07-30
Generating hepatocytes
Grant 10,227,565 - Zhu , et al.
2019-03-12
Reprogramming fibroblasts into cardiomyocytes
Grant 10,144,915 - Wang , et al. De
2018-12-04
Substituted benzoxazine and related compounds
Grant 10,087,151 - Tsvetkov , et al. October 2, 2
2018-10-02
Methods for reprogramming differentiated non-cardiac cells into cardiomyocytes
Grant 9,982,231 - Cao , et al. May 29, 2
2018-05-29
Generating definitive endoderm and pancreatic progenitor cells
Grant 9,909,104 - Ding , et al. March 6, 2
2018-03-06
Generating hepatocytes
Grant 9,512,406 - Zhu , et al. December 6, 2
2016-12-06
Small molecule inhibitors of kynurenine-3-monooxygenase
Grant 8,466,182 - Muchowski , et al. June 18, 2
2013-06-18
Small molecule inhibitors of kynurenine-3-monooxygenase
Grant 8,071,631 - Muchowski , et al. December 6, 2
2011-12-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed